Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HIV-1 REPLICATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 229 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kalinkovich, A; Borkow, G; Weisman, Z; Tsimanis, A; Stein, M; Bentwich, Z
      Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors

      CLINICAL IMMUNOLOGY
    2. Miller, MD; Hazuda, DJ
      New antiretroviral agents: looking beyond protease and reverse transcriptase

      CURRENT OPINION IN MICROBIOLOGY
    3. Buchschacher, GL; Wong-Staal, F
      Approaches to gene therapy for human immunodeficiency virus infection

      HUMAN GENE THERAPY
    4. Unwalla, H; Banerjea, AC
      Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymestargeted to cleave HIV-1 TAT/Rev RNA

      BIOCHEMICAL JOURNAL
    5. An, WF; Telesnitsky, A
      Frequency of direct repeat deletion in a human immunodeficiency virus type1 vector during reverse transcription in human cells

      VIROLOGY
    6. Lapatschek, MS; Durr, S; Sutter, G; Wagner, H; Miethke, T
      Functional evaluation of HIV/SIV Nef as superantigen

      VIROLOGY
    7. Hudak, KA; Hammell, AB; Yasenchak, J; Tumer, NE; Dinman, JD
      A C-terminal deletion mutant of pokeweed antiviral protein inhibits programmed+1 ribosomal frameshifting and Ty1 retrotransposition without depurinating the sarcin/ricin loop of rRNA

      VIROLOGY
    8. Kameoka, M; Rong, LW; Gotte, M; Liang, C; Russell, RS; Wainberg, MA
      Role for human immunodeficiency virus type 1 Tat protein in suppression ofviral reverse transcriptase activity during late stages of viral replication

      JOURNAL OF VIROLOGY
    9. Ross, HL; Nonnemacher, MR; Hogan, TH; Quiterio, SJ; Henderson, A; McAllister, JJ; Krebs, FC; Wigdahl, B
      Interaction between CCAAT/enhancer binding protein and cyclic AMP responseelement binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage

      JOURNAL OF VIROLOGY
    10. Lee, ES; Zhou, HY; Henderson, AJ
      Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism

      JOURNAL OF VIROLOGY
    11. Jimenez, JL; Gonzalez-Nicolas, J; Alvarez, S; Fresno, M; Munoz-Fernandez, MA
      Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide

      JOURNAL OF VIROLOGY
    12. Chang, SL; Griesgraber, W; Southern, PJ; Wagner, CR
      Amino acid phosphoramidate monoesters of 3 '-azido-3 '-deoxythymidine: Relationship between antiviral potency and intracellular metabolism

      JOURNAL OF MEDICINAL CHEMISTRY
    13. Weber, SM; Levitz, SM
      Chloroquine antagonizes the proinflammatory cytokine response to opportunistic fungi by alkalizing the fungal phagolysosome

      JOURNAL OF INFECTIOUS DISEASES
    14. Hiscott, J; Kwon, H; Genin, P
      Hostile takeovers: viral appropriation of the NF-kappa B pathway

      JOURNAL OF CLINICAL INVESTIGATION
    15. Hofmann, W; Reichart, B; Ewald, A; Muller, E; Schmitt, I; Stauber, RH; Lottspeich, F; Jockusch, BM; Scheer, U; Hauber, J; Dabauvalle, MC
      Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs: An unexpected role for actin

      JOURNAL OF CELL BIOLOGY
    16. Boelaert, JR; Sperber, K; Piette, J
      The additive in vitro anti-HIV-1 effect of chloroquine, when combined withzidovudine and hydroxyurea

      BIOCHEMICAL PHARMACOLOGY
    17. Hiratou, T; Miyano-Kurosaki, N; Tsukahara, S; Tamura, Y; Takai, K; Yamamoto, N; Takaku, H
      Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    18. Sherry, B; Schmidtmayerova, H; Zybarth, G; Dubrovsky, L; Raabe, T; Bukrinsky, M
      Nitric oxide regulates MIP-1 alpha expression in primary macrophages and Tlymphocytes: Implications for anti-HIV-1 response

      MOLECULAR MEDICINE
    19. Grattendick, K; Jansen, DB; Lefkowitz, DL; Lefkowitz, SS
      Cocaine causes increased type I interferon secretion by both L929 cells and murine macrophages

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    20. Lisziewicz, J; Zeng, G; Gratas, C; Weinstein, JN; Lori, F
      Combination gene therapy: Synergistic inhibition of human immunodeficiencyvirus Tat and Rev functions by a single RNA molecule

      HUMAN GENE THERAPY
    21. Mautino, MR; Ramsey, WJ; Reiser, J; Morgan, RA
      Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant rev

      HUMAN GENE THERAPY
    22. Mautino, MR; Morgan, RA
      Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA

      HUMAN GENE THERAPY
    23. Kohn, DB
      Transduction of CD34+cells from the bone marrow of HIV-1-infected children: Comparative marking by an RRE decoy gene and a neutral gene

      HUMAN GENE THERAPY
    24. Condos, R; Rom, WN; Weiden, M
      Lung-specific immune response in tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    25. De Clercq, E
      Structures and activities of non-nucleoside reverse transcriptase inhibitors (NNRTIs).

      MEDECINE ET MALADIES INFECTIEUSES
    26. Mirochnick, M; Clarke, DF; Dorenbaum, A
      Nevirapine - Pharmacokinetic considerations in children and pregnant women

      CLINICAL PHARMACOKINETICS
    27. Sriram, B; Banerjea, AC
      In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression

      BIOCHEMICAL JOURNAL
    28. Clayette, P; Martin, M; Beringue, V; Dereuddre-Bosquet, N; Adjou, KT; Seman, M; Dormont, D
      Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factoralpha synthesis and human immunodeficiency virus replication in macrophages

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    29. Imai, H; Oishi, T; Kikuchi, T; Hirama, M
      Concise Synthesis of 3-O-(2-O-alpha-D-glucopyranosyl-6-O-acyl-alpha-D-glucopyranosyl)-1,2-di-O-acyl-sn-glycerols

      TETRAHEDRON
    30. Brukstus, A; Melamedaite, D; Tumkevicius, S
      A facile synthesis of benzo[4,5]imidazo[2,1-b]pyrimido[5,4-f][1,3,4]thiadiazepines

      SYNTHETIC COMMUNICATIONS
    31. Gage, JR; Sandhu, AK; Nihira, M; Bonecini-Almeida, MD; Cristoforoni, P; Kishimoto, T; Montz, FJ; Martinez-Maza, O
      Effects of human papillomavirus-associated cells on human immunodeficiencyvirus gene expression

      OBSTETRICS AND GYNECOLOGY
    32. Dezube, BJ; Dahl, TA; Wong, TK; Chapman, B; Ono, M; Yamaguchi, N; Gillies, SD; Chen, LB; Crumpacker, CS
      A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: A phase I study

      JOURNAL OF INFECTIOUS DISEASES
    33. Moriuchi, H; Moriuchi, M; Mizell, SB; Ehler, LA; Fauci, AS
      In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4(+) T cells after bacterial stimulation

      JOURNAL OF INFECTIOUS DISEASES
    34. Dybul, M; Chun, TW; Ward, DJ; Hertogs, K; Larder, B; Fox, CH; Orenstein, JM; Baird, BF; Li, YX; Green, LG; Engel, D; Liu, SY; Mican, JM; Fauci, AS
      Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor-sparing highly active antiretroviral therapy

      JOURNAL OF INFECTIOUS DISEASES
    35. Schooley, RT; Mladenovic, J; Sevin, A; Chiu, S; Miles, SA; Pomerantz, RJ; Campbell, TB; Bell, D; Ambruso, D; Wong, R; Landay, A; Coombs, RW; Fox, L; Kamoun, M; Jacovini, J
      Reduced mobilization of CD34(+) stem cells in advanced human immunodeficiency virus type 1 disease

      JOURNAL OF INFECTIOUS DISEASES
    36. Jourdan, P; Vendrell, JP; Huguet, MF; Segondy, M; Bousquet, J; Pene, J; Yssel, H
      Cytokines and cell surface molecules independently induce CXCR4 expressionon CD4(+) CCR7(+) human memory T cells

      JOURNAL OF IMMUNOLOGY
    37. Jewell, NA; Mansky, LM
      In the beginning: genome recognition, RNA encapsidation and the initiationof complex retrovirus assembly

      JOURNAL OF GENERAL VIROLOGY
    38. Orendi, JM; Nottet, HSLM; de Vos, NM; Visser, MR; Snippe, H; Boucher, CAB; Verhoef, J
      Hydroxyurea interferes with antigen-dependent T-cell activation in vitro

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    39. Soriano, V; Rodriguez-Rosado, R; Lahoz, JG
      Rescue anti-retroviral therapy

      REVISTA CLINICA ESPANOLA
    40. La Maestra, L; Zaninoni, A; Marriott, JB; Lazzarin, A; Dalgleish, AG; Barcellini, W
      The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    41. Park, WS; Miyano-Kurosaki, N; Abe, T; Takai, K; Yamamoto, N; Takaku, H
      Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNAchimeric oligonucleotides

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    42. Segal, DM; Perez, M; Shapshak, P
      Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    43. Godard, CM; Chermann, JC
      Experimental conditions that increase the production of HIV-1 by monocyte-derived macrophages: use of collagen matrix

      MICROBES AND INFECTION
    44. Bellocq, A; Israel-Biet, D; Cadranel, J; Perez, J; Fouqueray, B; Kanfer, A; Girot, R; Baud, L
      Reduction of tumour necrosis factor alpha expression and signalling in peripheral blood mononuclear cells from patients with thalassaemia or sickle cell anaemia upon treatment with desferrioxamine

      CYTOKINE
    45. Fujiwara, M; Kodama, EN; Okamoto, M; Tokuhisa, K; Ide, T; Hanasaki, Y; Katsuura, K; Takayama, H; Aimi, N; Mitsuya, H; Shigeta, S; Konno, K; Yokota, T; Baba, M
      Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    46. Critchfield, JW; Ho, O; Roberts, BD; Van Lint, C; Verdin, E; Butera, ST
      Isoquinolinesulphonamide derivatives inhibit transcriptional elongation ofhuman immunodeficiency virus type 1 RNA in a promyelocytic model of latency

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    47. Taylor, DL; Ahmed, PS; Chambers, P; Tyms, AS; Bedard, J; Duchaine, J; Falardeau, G; Lavallee, JF; Brown, W; Rando, RF; Bowlin, T
      Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    48. Gate, L; Paul, J; Ba, GN; Tew, KD; Tapiero, H
      Oxidative stress induced in pathologies: the role of antioxidants

      BIOMEDICINE & PHARMACOTHERAPY
    49. Muotri, AR; Pereira, LD; Vasques, LD; Menck, CFM
      Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function

      GENE
    50. Medina, MFC; Joshi, S
      Design, characterization and testing of tRNA(3)(Lys)-based hammerhead ribozymes

      NUCLEIC ACIDS RESEARCH
    51. Prins, JM; Jurriaans, S; van Praag, RME; Blaak, H; van Rij, R; Schellekens, PTA; ten Berge, IJM; Yong, SL; Fox, CH; Roos, MTL; de Wolf, F; Goudsmit, J; Schuitemaker, H; Lange, JMA
      Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

      AIDS
    52. Rossi, C; Gibellini, D; Barbanti-Brodano, G; Betti, M; Boarini, C; Pengue, G; Lania, L; Caputo, A
      Transiently transfected and stably integrated HIV-1 LTR responds differentially to the silencing activity of the Kruppel-associated box (KRAB) transcriptional repressor domain

      JOURNAL OF MEDICAL VIROLOGY
    53. Pertel, SS; Kadun, AL; Kakayan, ES; Chirva, VY; Krivorutchenko, YL; Krivoshein, YS; Bakova, AA; Andronovskaya, IB
      The synthesis and biological activities of anomeric butyl glycosides of muramyl dipeptide

      BIOORGANICHESKAYA KHIMIYA
    54. Thompson, JD
      Strategies to express structural and catalytic RNAs in mammalian cells

      EXPRESSION OF RECOMBINANT GENES IN EUKARYOTIC SYSTEMS
    55. Korin, YD; Zack, JA
      Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G(0) lymphocytes

      JOURNAL OF VIROLOGY
    56. Truong, MJ; Darcissac, ECA; Hermann, E; Dewulf, J; Capron, A; Bahr, GM
      Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells

      JOURNAL OF VIROLOGY
    57. Pyeon, D; Splitter, GA
      Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and-10

      JOURNAL OF VIROLOGY
    58. Mai, A; Artico, M; Sbardella, G; Massa, S; Novellino, E; Greco, G; Loi, AG; Tramontano, E; Marongiu, ME; La Colla, P
      5-alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones: Novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    59. Nielsen, SD; Clark, DR; Hutchings, M; Dam-Larsen, S; Repping, S; Nielsen, JO; Mathiesen, L; Miedema, F; Hansen, JES
      Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons

      JOURNAL OF INFECTIOUS DISEASES
    60. Rosorius, O; Reichart, B; Kratzer, F; Heger, P; Dabauvalle, MC; Hauber, J
      Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1

      JOURNAL OF CELL SCIENCE
    61. Hermann, E; Darcissac, E; Idziorek, T; Capron, A; Bahr, GM
      Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells

      IMMUNOLOGY
    62. Schirmeister-Tichy, H; Iacono, KT; Muto, NF; Homan, JW; Suhadolnik, RJ; Pfleiderer, W
      Nucleotides - Part LIX - Synthesis, characterization, and biological activities of new potential antiviral agents: (2 '-5 ')adenylate trimer analogs containing 3 '-deoxy-3 '(hexadecanoylamino)adenosine at the 2 '-terminus

      HELVETICA CHIMICA ACTA
    63. Kvasyuk, EI; Mikhailopulo, IA; Homan, JW; Iacono, KT; Muto, NF; Suhadolnik, RJ; Pfleiderer, W
      Nucleotides - Part LVIII - Synthesis and biological activity of (2 '-5 ')oligoadenylate trimers containing a 5 '-terminal 5 '-amino-5 '-deoxy- or 5 '-amino-3 ',5 '-dideoxyadenosine derivative

      HELVETICA CHIMICA ACTA
    64. Ryo, A; Suzuki, Y; Ichiyama, K; Wakatsuki, T; Kondoh, N; Hada, A; Yamamoto, M; Yamamoto, N
      Serial analysis of gene expression in HIV-1-infected T cell lines

      FEBS LETTERS
    65. Di Francesco, P; Lisi, A; Rieti, S; Manni, V; Grimaldi, S; Garaci, E
      Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    66. Persichini, T; Colasanti, M; Fraziano, M; Colizzi, V; Ascenzi, P; Lauro, GM
      Nitric oxide inhibits HIV-1 replication in human astrocytoma cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    67. HOLTZER CD; COLEMAN RL
      USE OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS

      American journal of health-system pharmacy
    68. AYEHUNIE S; BELAY A; BABA TW; RUPRECHT RM
      INHIBITION OF HIV-1 REPLICATION BY AN AQUEOUS EXTRACT OF SPIRULINA-PLATENSIS (ARTHROSPIRA-PLATENSIS)

      Journal of acquired immune deficiency syndromes and human retrovirology
    69. MILNE GWA; NICKLAUS MC; WANG S
      PHARMACOPHORES IN DRUG DESIGN AND DISCOVERY

      SAR and QSAR in environmental research (Print)
    70. PHYLACTOU LA; KILPATRICK MW; WOOD MJA
      RIBOZYMES AS THERAPEUTIC TOOLS FOR GENETIC-DISEASE

      Human molecular genetics (Print)
    71. VIG R; MAO C; VENKATACHALAM TK; TUELAHLGREN L; SUDBECK EA; UCKUN FM
      LTHIOMETHYL)THIO]-6-(BENZYL)-PYRIMIDIN-4-(1H)-ONES AS POTENT NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS OF S-DABO SERIES

      Bioorganic & medicinal chemistry letters
    72. WELCH PJ; BARBER JR; WONGSTAAL F
      EXPRESSION OF RIBOZYMES IN GENE-TRANSFER SYSTEMS TO MODULATE TARGET RNA LEVELS

      Current opinion in biotechnology
    73. RENOUDGRAPPIN M; FOSSEY C; FONTAINE G; LADUREE D; AUBERTIN AM; KIRN A
      IMIDAZO[1,5-B]PYRIDAZINE-D4T CONJUGATES - SYNTHESIS AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS EVALUATION

      Antiviral chemistry & chemotherapy
    74. SHAO X; RYTTING AS; EKSTRAND DHL; VRANG L; KALLANDER CFR; GRONOWITZ JS
      COLORIMETRIC ASSAYS FOR EVALUATION OF THE MODE OF ACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS

      Antiviral chemistry & chemotherapy
    75. KERSTEN MJ; VERDUYN TJ; REISS P; EVERS LM; DEWOLF F; VANOERS MHJ
      TREATMENT OF AIDS-RELATED NON-HODGKINS-LYMPHOMA WITH CHEMOTHERAPY (CNOP) AND R-HN-G-CSF - CLINICAL OUTCOME AND EFFECT ON HIV-1 VIRAL LOAD

      Annals of oncology
    76. BUNNELL BA; MORGAN RA
      GENE-THERAPY FOR INFECTIOUS-DISEASES

      Clinical microbiology reviews
    77. BIBOLLETRUCHE F; LOUSSERTAJAKA I; SIMON F; MBOUP S; NGOLE EM; SAMAN E; DELAPORTE E; PEETERS M
      GENETIC-CHARACTERIZATION OF ACCESSORY GENES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GROUP-O STRAINS

      AIDS research and human retroviruses
    78. KOIZUMI M; OZAWA Y; YAGI R; NISHIGAKI T; KANEKO M; OKA S; KIMURA S; IWAMOTO A; KOMATSU Y; OHTSUKA E
      DESIGN AND ANTI-HIV-1 ACTIVITY OF HAMMERHEAD AND HAIRPIN RIBOZYMES CONTAINING A STABLE LOOP

      Nucleosides & nucleotides
    79. ISAKA Y; SATO A; KAWAUCHI S; SUYAMA A; MIKI S; HAYAMI M; FUJIWARA T
      CONSTRUCTION OF THE CHIMERIC REVERSE-TRANSCRIPTASE OF SIMIAN IMMUNODEFICIENCY VIRUS SENSITIVE TO NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR

      Microbiology and immunology
    80. BRAMLAGE B; LUZI E; ECKSTEIN F
      DESIGNING RIBOZYMES FOR THE INHIBITION OF GENE-EXPRESSION

      Trends in biotechnology
    81. Mortola, E; Endo, Y; Ohno, K; Watari, T; Tsujimoto, H; Hasegawa, A
      The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus

      VETERINARY RESEARCH COMMUNICATIONS
    82. HAFFAR OK; SMITHGALL MD; POPOV S; ULRICH P; BRUCE AG; NADLER SG; CERAMI A; BUKRINSKY MI
      CNI-H0294, A NUCLEAR IMPORTATION INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENOME, ABROGATES VIRUS-REPLICATION IN INFECTED ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      Antimicrobial agents and chemotherapy
    83. Miller, V; de Bethune, RP; Kober, A; Sturmer, M; Hertogs, K; Pauwels, R; Stoffels, P; Staszewski, S
      Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    84. Sudbeck, EA; Mao, C; Vig, R; Venkatachalam, TK; Tuel-Ahlgren, L; Uckun, FM
      Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    85. ALVAREZSALAS LM; CULLINAN AE; SIWKOWSKI A; HAMPEL A; DIPAOLO JA
      INHIBITION OF HPV-16 E6 E7 IMMORTALIZATION OF NORMAL KERATINOCYTES BYHAIRPIN RIBOZYMES/

      Proceedings of the National Academy of Sciences of the United Statesof America
    86. NAVARRO J; PUNZON C; JIMENEZ JL; FERNANDEZCRUZ E; PIZARRO A; FRESNO M; MUNOZFERNANDEZ A
      INHIBITION OF PHOSPHODIESTERASE TYPE-IV SUPPRESSES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION AND CYTOKINE PRODUCTION IN PRIMARY T-CELLS - INVOLVEMENT OF NF-KAPPA-B AND NFAT

      Journal of virology
    87. VERES G; JUNKER U; BAKER J; BARSKE C; KALFOGLOU C; ILVES H; ESCAICH S; KANESHIMA H; BOHNLEIN E
      COMPARATIVE ANALYSES OF INTRACELLULARLY EXPRESSED ANTISENSE RNAS AS INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION

      Journal of virology
    88. MAITRA RK; SILVERMAN RH
      REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY 2',5'-OLIGOADENYLATE-DEPENDENT RNASE-L

      Journal of virology
    89. BURKHOLDER C; DOLBIER WR; MEDEBIELLE M
      TETRAKIS(DIMETHYLAMINO)ETHYLENE AS A USEFUL REDUCTANT OF SOME BROMODIFLUOROMETHYL HETEROCYCLES - APPLICATION TO THE SYNTHESIS OF NEW GEM-DIFLUORINATED HETEROARYLATED COMPOUNDS

      Journal of organic chemistry
    90. BERGERON RJ; WEIMAR WR; MULLER R; ZIMMERMAN CO; MCCOSAR BH; YAO H; SMITH RE
      SYNTHESIS OF REAGENTS FOR THE CONSTRUCTION OF HYPUSINE AND DEOXYHYPUSINE PEPTIDES AND THEIR APPLICATION AS PEPTIDIC ANTIGENS

      Journal of medicinal chemistry
    91. BERGERON RJ; WEIMAR WR; MULLER R; ZIMMERMAN CO; MCCOSAR BH; YAO H; SMITH RE
      EFFECT OF POLYAMINE ANALOGS ON HYPUSINE CONTENT IN JURKAT T-CELLS

      Journal of medicinal chemistry
    92. GRIFFITHS PD
      STUDIES OF VIRAL COFACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS IN-VITRO AND IN-VIVO

      Journal of General Virology
    93. GAO WY; ZHOU BS; JOHNS DG; MITSUYA H; YEN Y
      ROLE OF THE M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE IN REGULATION BY HYDROXYUREA OF THE ACTIVITY OF THE ANTI-HIV-1 AGENT 2',3'-DIDEOXYINOSINE

      Biochemical pharmacology
    94. ROSSI JJ
      THERAPEUTIC RIBOZYMES - PRINCIPLES AND APPLICATIONS

      Biodrugs
    95. JOHNS DG; GAO WY
      SELECTIVE DEPLETION OF DNA PRECURSORS - AN EVOLVING STRATEGY FOR POTENTIATION OF DIDEOXYNUCLEOSIDE ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS

      Biochemical pharmacology
    96. ROSSI C; BALBONI PG; BETTI M; MARCONI PC; BOZZINI R; GROSSI MP; BARBANTIBRODANO G; CAPUTO A
      INHIBITION OF HIV-1 REPLICATION BY A TAT TRANSDOMINANT NEGATIVE MUTANT IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTES FROM HEALTHY DONORS AND HIV-1-INFECTED PATIENTS

      Gene therapy
    97. AGATSUMA T; FURUKAWA H; HOTODA H; KOIZUMI M; KOGA R; KANEKO M
      ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF R-95288, A PHOSPHODIESTER HEXADEOXYRIBONUCLEOTIDE MODIFIED BY DIBENZYLOXYBENZYL AND HYDROXYETHYL RESIDUES AT THE 5'-ENDS AND 3'-ENDS

      Antiviral chemistry & chemotherapy
    98. BAERTSCHI SW; CANTRELL AS; KUHFELD MT; LORENZ LJ; BOYD DB; JASKUNAS SR
      INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY DEGRADATION PRODUCTS OF CEFTAZIDIME

      Antiviral chemistry & chemotherapy
    99. JOURDAN F; RENAULT J; FOSSEY C; BUREAU R; LADUREE D; ROBBA M; AUBERTIN AM; KIRN A
      DESIGN, SYNTHESIS AND ANTIVIRAL ACTIVITY OF NEW PYRIDINONE DERIVATIVES

      Antiviral chemistry & chemotherapy
    100. SEN CK; ROY S; HAN D; PACKER L
      REGULATION OF CELLULAR THIOLS IN HUMAN-LYMPHOCYTES BY ALPHA-LIPOIC ACID - A FLOW CYTOMETRIC ANALYSIS

      Free radical biology & medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 05:25:00